GBIO
Price
$4.17
Change
-$0.11 (-2.57%)
Updated
Aug 7, 04:59 PM (EDT)
Capitalization
27.81M
90 days until earnings call
INVA
Price
$18.46
Change
+$0.21 (+1.15%)
Updated
Aug 7, 04:59 PM (EDT)
Capitalization
1.16B
83 days until earnings call
Interact to see
Advertisement

GBIO vs INVA

Header iconGBIO vs INVA Comparison
Open Charts GBIO vs INVABanner chart's image
Generation Bio
Price$4.17
Change-$0.11 (-2.57%)
Volume$200
Capitalization27.81M
Innoviva
Price$18.46
Change+$0.21 (+1.15%)
Volume$18.39K
Capitalization1.16B
GBIO vs INVA Comparison Chart in %
Loading...
GBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GBIO vs. INVA commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GBIO is a StrongBuy and INVA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 08, 2025
Stock price -- (GBIO: $4.15 vs. INVA: $18.46)
Brand notoriety: GBIO and INVA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GBIO: 36% vs. INVA: 163%
Market capitalization -- GBIO: $27.81M vs. INVA: $1.16B
GBIO [@Biotechnology] is valued at $27.81M. INVA’s [@Biotechnology] market capitalization is $1.16B. The market cap for tickers in the [@Biotechnology] industry ranges from $199.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GBIO’s FA Score shows that 0 FA rating(s) are green whileINVA’s FA Score has 1 green FA rating(s).

  • GBIO’s FA Score: 0 green, 5 red.
  • INVA’s FA Score: 1 green, 4 red.
According to our system of comparison, INVA is a better buy in the long-term than GBIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GBIO’s TA Score shows that 4 TA indicator(s) are bullish while INVA’s TA Score has 3 bullish TA indicator(s).

  • GBIO’s TA Score: 4 bullish, 5 bearish.
  • INVA’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, GBIO is a better buy in the short-term than INVA.

Price Growth

GBIO (@Biotechnology) experienced а -6.53% price change this week, while INVA (@Biotechnology) price change was +1.60% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.18%. For the same industry, the average monthly price growth was +8.39%, and the average quarterly price growth was +12.02%.

Reported Earning Dates

GBIO is expected to report earnings on Nov 05, 2025.

INVA is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Biotechnology (+1.18% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INVA($1.16B) has a higher market cap than GBIO($27.8M). INVA YTD gains are higher at: 5.187 vs. GBIO (-59.623). INVA has higher annual earnings (EBITDA): 681K vs. GBIO (-69.2M). INVA has more cash in the bank: 447M vs. GBIO (46.7M). GBIO has less debt than INVA: GBIO (87.6M) vs INVA (451M). INVA has higher revenues than GBIO: INVA (370M) vs GBIO (24.6M).
GBIOINVAGBIO / INVA
Capitalization27.8M1.16B2%
EBITDA-69.2M681K-10,162%
Gain YTD-59.6235.187-1,149%
P/E RatioN/A32.39-
Revenue24.6M370M7%
Total Cash46.7M447M10%
Total Debt87.6M451M19%
FUNDAMENTALS RATINGS
INVA: Fundamental Ratings
INVA
OUTLOOK RATING
1..100
58
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
PROFIT vs RISK RATING
1..100
63
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
59
P/E GROWTH RATING
1..100
2
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GBIOINVA
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
77%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
63%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
60%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
54%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
60%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
60%
Advances
ODDS (%)
Bullish Trend 11 days ago
86%
Bullish Trend 23 days ago
67%
Declines
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
64%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
55%
View a ticker or compare two or three
Interact to see
Advertisement
GBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SEEFX20.73N/A
N/A
Saturna Sustainable Equity
HIISX16.49N/A
N/A
Harbor International Small Cap Investor
CBBZX6.61N/A
N/A
AB Relative Value Z
TASMX28.30N/A
N/A
Transamerica Small/Mid Cap Value R6
OAZLX80.87-0.50
-0.61%
Oakmark Select R6

GBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, GBIO has been loosely correlated with ATXS. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if GBIO jumps, then ATXS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GBIO
1D Price
Change %
GBIO100%
-6.14%
ATXS - GBIO
47%
Loosely correlated
-0.57%
IDYA - GBIO
47%
Loosely correlated
-2.03%
GLSI - GBIO
46%
Loosely correlated
+3.24%
IPSC - GBIO
44%
Loosely correlated
-2.80%
ATNM - GBIO
44%
Loosely correlated
-1.23%
More

INVA and

Correlation & Price change

A.I.dvisor indicates that over the last year, INVA has been loosely correlated with GBIO. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if INVA jumps, then GBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INVA
1D Price
Change %
INVA100%
-1.03%
GBIO - INVA
41%
Loosely correlated
-6.14%
SLNO - INVA
37%
Loosely correlated
-0.54%
ALNY - INVA
36%
Loosely correlated
+2.20%
KYMR - INVA
35%
Loosely correlated
-3.77%
NRIX - INVA
35%
Loosely correlated
-7.52%
More